If Ji paid them in anything but SRNE shares then he is irresponsible. Assuming he did it's also a good sign of positive things to come as he would have to disclose any material issues during due diligence. I assume SmartPharma's venture capital / PE backers would have looked at SRNE's stock value and potential before agreeing to the deal. If Ji misled them it's an automatic lawsuit which he loses.
Market Data 
Markets 
